Abbott/Kos’ Integrated Sales Force Expected To Accelerate Niaspan Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott says there will be “synergistic” effects from folding Niaspan into its cholesterol portfolio that will improve sales over those seen when Kos was the sole marketer.